
Biomarkers in gynecological cancer : the potential of tumor infiltrating immune cells and circulating extracellular vesicles
(2022)
- Author
- Lien Lippens (UGent)
- Promoter
- Hannelore Denys (UGent) , An Hendrix (UGent) and Katrien Vandecasteele (UGent)
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8770292
- MLA
- Lippens, Lien. Biomarkers in Gynecological Cancer : The Potential of Tumor Infiltrating Immune Cells and Circulating Extracellular Vesicles. Ghent University. Faculty of Medicine and Health Sciences, 2022.
- APA
- Lippens, L. (2022). Biomarkers in gynecological cancer : the potential of tumor infiltrating immune cells and circulating extracellular vesicles. Ghent University. Faculty of Medicine and Health Sciences, Ghent, Belgium.
- Chicago author-date
- Lippens, Lien. 2022. “Biomarkers in Gynecological Cancer : The Potential of Tumor Infiltrating Immune Cells and Circulating Extracellular Vesicles.” Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences.
- Chicago author-date (all authors)
- Lippens, Lien. 2022. “Biomarkers in Gynecological Cancer : The Potential of Tumor Infiltrating Immune Cells and Circulating Extracellular Vesicles.” Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences.
- Vancouver
- 1.Lippens L. Biomarkers in gynecological cancer : the potential of tumor infiltrating immune cells and circulating extracellular vesicles. [Ghent, Belgium]: Ghent University. Faculty of Medicine and Health Sciences; 2022.
- IEEE
- [1]L. Lippens, “Biomarkers in gynecological cancer : the potential of tumor infiltrating immune cells and circulating extracellular vesicles,” Ghent University. Faculty of Medicine and Health Sciences, Ghent, Belgium, 2022.
@phdthesis{8770292, author = {{Lippens, Lien}}, language = {{eng}}, pages = {{X, 244}}, publisher = {{Ghent University. Faculty of Medicine and Health Sciences}}, school = {{Ghent University}}, title = {{Biomarkers in gynecological cancer : the potential of tumor infiltrating immune cells and circulating extracellular vesicles}}, year = {{2022}}, }